{
    "ticker": "VIRX",
    "name": "Virax Biolabs Group Limited",
    "description": "Virax Biolabs Group Limited is a biotechnology company focused on developing and commercializing innovative health solutions. Founded in 2020 and headquartered in Singapore, Virax is dedicated to addressing the global health challenges posed by infectious diseases, particularly in the context of viral diagnostics and therapeutics. The company specializes in the research and development of advanced diagnostic tests for various viral infections, including COVID-19 and other infectious diseases that pose significant health risks. Through its proprietary technology and strategic partnerships, Virax aims to provide rapid, accurate, and cost-effective solutions that enhance disease detection, management, and prevention. The company's mission is to improve public health outcomes by making high-quality diagnostics accessible globally. With a commitment to scientific excellence and innovative approaches, Virax is positioned to make a meaningful impact in the healthcare sector, particularly as the world continues to combat the ongoing effects of infectious diseases.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Singapore",
    "founded": "2020",
    "website": "https://www.viraxbiolabs.com",
    "ceo": "James Foster",
    "social_media": {
        "linkedin": "https://www.linkedin.com/company/virax-biolabs/"
    },
    "investor_relations": "https://www.viraxbiolabs.com/investors",
    "key_executives": [
        {
            "name": "James Foster",
            "position": "CEO"
        },
        {
            "name": "Dr. Paul A. Williams",
            "position": "Chief Scientific Officer"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Tests",
            "products": [
                "COVID-19 Rapid Test",
                "Viral Infection Screening Tests"
            ]
        },
        {
            "category": "Therapeutics",
            "products": [
                "Antiviral Treatments"
            ]
        }
    ],
    "seo": {
        "meta_title": "Virax Biolabs Group Limited | Innovative Health Solutions",
        "meta_description": "Virax Biolabs Group Limited focuses on developing advanced diagnostics and therapeutics for infectious diseases, improving global health outcomes.",
        "keywords": [
            "Virax Biolabs",
            "Biotechnology",
            "Diagnostics",
            "Infectious Diseases",
            "COVID-19",
            "Health Solutions"
        ]
    },
    "faq": [
        {
            "question": "What does Virax Biolabs specialize in?",
            "answer": "Virax Biolabs specializes in developing diagnostic tests and therapeutics for infectious diseases."
        },
        {
            "question": "Who is the CEO of Virax Biolabs?",
            "answer": "James Foster is the CEO of Virax Biolabs Group Limited."
        },
        {
            "question": "Where is Virax Biolabs headquartered?",
            "answer": "Virax Biolabs is headquartered in Singapore."
        },
        {
            "question": "What are the main products of Virax Biolabs?",
            "answer": "Virax Biolabs' main products include COVID-19 rapid tests and antiviral treatments."
        },
        {
            "question": "When was Virax Biolabs founded?",
            "answer": "Virax Biolabs was founded in 2020."
        }
    ],
    "competitors": [
        "BDX",
        "ABBV",
        "PFE",
        "MRNA"
    ],
    "related_stocks": [
        "JNJ",
        "AMGN",
        "GILD",
        "NVAX"
    ]
}